Global Opioid Use Disorder Market Growth (Status and Outlook) 2023-2029

Global Opioid Use Disorder Market Growth (Status and Outlook) 2023-2029

An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.

LPI (LP Information)' newest research report, the “Opioid Use Disorder Industry Forecast” looks at past sales and reviews total world Opioid Use Disorder sales in 2022, providing a comprehensive analysis by region and market sector of projected Opioid Use Disorder sales for 2023 through 2029. With Opioid Use Disorder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Use Disorder industry.

This Insight Report provides a comprehensive analysis of the global Opioid Use Disorder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid Use Disorder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Opioid Use Disorder market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Use Disorder and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Use Disorder.

The global Opioid Use Disorder market size is projected to grow from US$ 1709.7 million in 2022 to US$ 2556.1 million in 2029; it is expected to grow at a CAGR of 5.9% from 2023 to 2029.

Increase in opioid epidemic in the U.S. coupled with establishment of government policies to control the crisis is driving the market.

This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Use Disorder market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Buprenorphine
Methadone
Naltrexone

Segmentation by application
Moderate Pain Treatment
Severe Pain Treatment

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Indivior
Alkermes
Titan Pharmaceuticals
Hikma Pharmaceuticals
Teva Pharmaceuticals
MediciNova
Orexo
Camurus
Omeros

Please note: The report will take approximately 2 business days to prepare and deliver.